NRIX logo

ARKG Holdings of NRIX

Nurix Pharmaceuticals

Nurix Therapeutics is a biopharmaceutical company focused on discovering and developing targeted protein modulation drugs to treat various diseases, including cancer. The company generates revenue through a combination of strategic collaborations with larger pharmaceutical firms and the advancement of its internal drug development programs.

Trades of NRIX in ARKG

The ten most recent trades of Nurix Pharmaceuticals in the ARKG ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Nov 19, 2024Sell$687,6372.00%0.06%
Nov 18, 2024Sell$193,6670.57%0.02%
Nov 15, 2024Sell$184,5610.47%0.02%
Nov 08, 2024Sell$640,7291.47%0.05%
Nov 05, 2024Sell$1,829,1584.43%0.15%
Nov 04, 2024Sell$609,9911.46%0.05%
Nov 01, 2024Sell$1,267,1742.97%0.11%
Oct 30, 2024Sell$98,0980.23%0.01%
Oct 29, 2024Sell$2,238,0334.77%0.18%
Jun 20, 2024Sell$713,1211.36%0.05%